90 related articles for article (PubMed ID: 3171926)
1. Percutaneous absorption of sulconazole nitrate in humans.
Franz TJ; Lehman P
J Pharm Sci; 1988 Jun; 77(6):489-91. PubMed ID: 3171926
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cutaneous Sulconazole nitrate in the hairless rat: absorption, excretion, tissue concentrations.
Hercelin B; Delaunay-Vantrou M; Alamichel F; Mazza M; Marty JP
Eur J Drug Metab Pharmacokinet; 1993; 18(2):149-54. PubMed ID: 8243497
[TBL] [Abstract][Full Text] [Related]
3. Systemic absorption of 3H-fenticonazole after vaginal administration of 1 gram in patients.
Novelli A; Periti E; Massi GB; Masi R; Mazzei T; Periti P
J Chemother; 1991 Feb; 3(1):23-7. PubMed ID: 2019858
[TBL] [Abstract][Full Text] [Related]
4. Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration.
Susilo R; Korting HC; Strauss UP; Menke G; Schuster O; Menke A
Arzneimittelforschung; 2005; 55(6):338-42. PubMed ID: 16032974
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption of amorolfine following a single topical application of an amorolfine cream formulation.
Roncari G; Ponelle C; Zumbrunnen R; Guenzi A; Dingemanse J; Jonkman JH
Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():33-6. PubMed ID: 1458662
[TBL] [Abstract][Full Text] [Related]
6. Difference in percutaneous absorption and intracutaneous distribution in guinea pigs among topical antifungal drugs (tioconazole solution, tioconazole cream, miconazole nitrate solution and bifonazole solution).
Sobue S; Sekiguchi K
Biol Pharm Bull; 2004 Sep; 27(9):1428-32. PubMed ID: 15340231
[TBL] [Abstract][Full Text] [Related]
7. Reversed-phase high-pressure liquid chromatographic analysis of sulconazole in plasma.
Fass M; Zaro B; Chaplin M; Matin S
J Pharm Sci; 1981 Dec; 70(12):1338-40. PubMed ID: 7320848
[TBL] [Abstract][Full Text] [Related]
8. Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability.
Barbanoj MJ; Antonijoan R; García-Gea C; Puntes M; Gich I; Jané F
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):227-34. PubMed ID: 16082423
[TBL] [Abstract][Full Text] [Related]
9. In vivo percutaneous absorption of acetochlor in the rhesus monkey: dose-response and exposure risk assessment.
Wester RC; Melendres JL; Maibach HI
Food Chem Toxicol; 1996 Oct; 34(10):979-83. PubMed ID: 9012773
[TBL] [Abstract][Full Text] [Related]
10. Experimental methods for determining permethrin dermal absorption.
Reifenrath WG; Ross JH; Driver JH
J Toxicol Environ Health A; 2011; 74(5):325-35. PubMed ID: 21240732
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tolerance of sertaconazole in man after repeated percutaneous administration.
Farré M; Ugena B; Badenas JM; Márquez M; Roset P; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):752-4. PubMed ID: 1627199
[TBL] [Abstract][Full Text] [Related]
12. Species variation in percutaneous absorption of sulconazole nitrate, a new anti-fungal agent.
Zaro BA; Hama KM; Chaplin MD
Proc West Pharmacol Soc; 1982; 25():357-9. PubMed ID: 7122521
[No Abstract] [Full Text] [Related]
13. Percutaneous absorption and skin distribution of [14C]flutrimazole in mini-pigs.
Conte L; Ramis J; Mis R; Forn J; Vilaró S; Reina M; Vilageliu J; Basi N
Arzneimittelforschung; 1992 Jun; 42(6):847-53. PubMed ID: 1418044
[TBL] [Abstract][Full Text] [Related]
14. Human systemic exposure to a [14C]-para-phenylenediamine-containing oxidative hair dye and correlation with in vitro percutaneous absorption in human or pig skin.
Hueber-Becker F; Nohynek GJ; Meuling WJ; Benech-Kieffer F; Toutain H
Food Chem Toxicol; 2004 Aug; 42(8):1227-36. PubMed ID: 15207372
[TBL] [Abstract][Full Text] [Related]
15. Sulconazole nitrate cream 1 percent for treating tinea cruris and corporis.
Tanenbaum L; Taplin D; Lavelle C; Akers WA; Rosenberg MJ; Carmargo G
Cutis; 1989 Oct; 44(4):344-7. PubMed ID: 2805811
[TBL] [Abstract][Full Text] [Related]
16. Absorption and disposition of econazole nitrate after application to the skins and vaginas of rabbits.
Cameron BD; Chasseaud LF; Conway B; Fox N; Taylor T
Arzneimittelforschung; 1976; 26(11):2054-9. PubMed ID: 1037247
[TBL] [Abstract][Full Text] [Related]
17. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.
Niwano Y; Matsui M; Tabuchi T; Kanai K; Hamaguchi H; Miyazaki T; Uchida K; Yamaguchi H
Arzneimittelforschung; 1997 Sep; 47(9):1056-60. PubMed ID: 9342423
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption of 14C-9alpha-fluoro-11beta,21-dihydroxy-3,20-dioxopregna-1,4-dieno (17alpha,16alpha-d)-2'-methyloxazolidine-21-acetate (L 6400) in rats, pigs and humans. Comparison with 3H-triamcinolone acetonide.
Lewis JD; Cameron BD; Hawkins DR; Chasseaud LF; Franklin ER
Arzneimittelforschung; 1975 Oct; 25(10):1646-50. PubMed ID: 54172
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazole.
Conte L; Ramis J; Mis R; Vilageliu J; Basi N; Forn J
Arzneimittelforschung; 1992 Jun; 42(6):854-8. PubMed ID: 1418045
[TBL] [Abstract][Full Text] [Related]
20. In vivo percutaneous absorption and skin decontamination of alachlor in rhesus monkey.
Wester RC; Melendres J; Maibach HI
J Toxicol Environ Health; 1992 May; 36(1):1-12. PubMed ID: 1588637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
